52 Week Range · Open Price $0 · Previous Close $0 · Volume Company profile page for Humanigen Inc including stock price, company news, executives, board members, and contact information. Humanigen reported progress with lenzilumab, which is designed to treat the immune hyperresponse called cytokine storm that hits some COVID victims. HGEN. Stock price history for Humanigen (HGEN). Highest end of day price: $ USD on Lowest end of day price: $ USD on The Humanigen stock forecast for tomorrow is $ , which would represent a % gain compared to the current price. In the next week, the price of HGEN is.
Financials Humanigen Inc.(HGENQ). Quarterly Annual. Net Income. 0. Humanigen Inc Stock Price (HGEN). Humanigen Inc is listed in the sector of the NASDAQ with ticker HGEN. The last closing price for Humanigen was $ Over the. Real time Humanigen (HGEN) stock price quote, stock graph, news & analysis. How to buy Humanigen stock on Public · Sign up for a brokerage account on Public · Add funds to your Public account · Choose how much you'd like to invest in. What is Humanigen Inc(HGENQ)'s stock price today? The current price of HGENQ is $ The 52 week high of HGENQ is $ and 52 week low is $ When is next. The Humanigen Inc stock price today is What Is the Stock Symbol for Humanigen Inc? The stock ticker symbol for Humanigen Inc is HGENQ. Is HGENQ the Same. Humanigen, Inc. is a clinical-stage biopharmaceutical company. It engages in the developing next-generation cell and gene therapies for the treatment of. Track Humanigen Inc (HGENQ) Stock Price, Quote, latest community messages, chart, news and other stock related information. shares of common stock at a public offering price of $ per share, resulting in gross proceeds to Humanigen of approximately $68 million, before. Humanigen Inc. (HGEN) Stock Performance ; S&P Small-Cap , , , ; BSE Sensex. , , , Is "Humanigen Inc" a Good Investment? Current price today: △ USD (+%). 7 Days Forecast. Get It Now!
Humanigen Inc (OTC:HGEN) Stock, Analyst Ratings, Price Targets, Forecasts. Humanigen Inc has a consensus price target of $ based on the ratings of 6. NASDAQ: HGEN ; Price. $ Volume. 7,, ; Change. + % Change. +% ; Today's Open. $ Previous Close. $ What was Humanigen's price range in the past 12 months? Humanigen lowest stock price was and its highest was $ in the past 12 months. Humanigen (HGEN) Stock Price, News & Analysis. Notice: This company has been marked as potentially delisted and may not be actively trading. Robinhood traders. The week high for Humanigen, Inc. Stock is $ and the week low is $ The historical data and Price History for Humanigen Inc (HGEN) with Intraday, Daily, Weekly, Monthly, and Quarterly data available for download. This stock is no longer active on Robinhood. Sign up for a Robinhood brokerage account to watch HGEN and buy and sell other stock and options commission-free. The Humanigen stock price prediction for tomorrow is $ , based on the current market trends. According to the prediction, the price of HGEN stock will. HGEN - Humanigen, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (OTCPK). Humanigen, Inc. OTCPK. THIS SYMBOL IS NO LONGER ACTIVE. REAL TIME.
To contextualize these metrics, consider that out of all US stocks, HUMANIGEN INC's upside potential (average analyst target price relative to current price) is. ; Volume: K · 65 Day Avg: K ; Day Range ; 52 Week Range HGEN - Humanigen, Inc. Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (OTCPK). A high-level overview of Humanigen, Inc. (HGENQ) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and. Humanigen Inc. company facts, information and financial ratios from MarketWatch stock quotes reflect trades reported through Nasdaq only. Intraday data.
Stock Price Statistics · Beta (5Y), ; Short Selling Information · Short Interest, M ; Income Statement · Gross Profit, M ; Balance Sheet · Cash & Cash. Compare HGEN With Other Stocks ; , , , , Recent News · Humanigen Downfall: FDA Rejection For COVID Drug Triggers Financial Crisis, Bankruptcy. Humanigen, previously linked with disgraced. Humanigen wins US patent for Lenzilumab in preventing cytokine storm and neurotoxicity Humanigen Inc (NASDAQ:HGEN) announced on Monday that the US Patent.